Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases
- PMID: 28223234
- DOI: 10.1016/j.pharmthera.2017.02.030
Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases
Abstract
Advanced glycation end products (AGEs) and their receptor have been implicated in the progressions of many intractable diseases, such as diabetes and atherosclerosis, and are also critical for pathologic changes in chronic degenerative diseases, such as Alzheimer's disease, Parkinson's disease, and alcoholic brain damage. Recently activated macrophages were found to be a source of AGEs, and the most abundant form of AGEs, AGE-albumin excreted by macrophages has been implicated in these diseases and to act through common pathways. AGEs inhibition has been shown to prevent the pathogenesis of AGEs-related diseases in human, and therapeutic advances have resulted in several agents that prevent their adverse effects. Recently, anti-inflammatory molecules that inhibit AGEs have been shown to be good candidates for ameliorating diabetic complications as well as degenerative diseases. This review was undertaken to present, discuss, and clarify current understanding regarding AGEs formation in association with macrophages, different diseases, therapeutic and diagnostic strategy and links with RAGE inhibition.
Keywords: Advanced glycation end products (AGEs); Degenerative diseases; Inflammation; Macrophage; Receptor for AGEs (RAGE).
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.
Similar articles
-
Age-related accumulation of advanced glycation end-products-albumin, S100β, and the expressions of advanced glycation end product receptor differ in visceral and subcutaneous fat.Biochem Biophys Res Commun. 2016 Aug 19;477(2):271-6. doi: 10.1016/j.bbrc.2016.06.056. Epub 2016 Jun 11. Biochem Biophys Res Commun. 2016. PMID: 27301641
-
Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.Int J Biochem Cell Biol. 2016 Dec;81(Pt B):403-418. doi: 10.1016/j.biocel.2016.06.016. Epub 2016 Jun 29. Int J Biochem Cell Biol. 2016. PMID: 27373680 Review.
-
Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.Glycoconj J. 2016 Aug;33(4):607-17. doi: 10.1007/s10719-016-9679-x. Epub 2016 Jun 8. Glycoconj J. 2016. PMID: 27277623 Review.
-
Activation of the receptor for advanced glycation end products and consequences on health.Diabetes Metab Syndr. 2017 Oct-Dec;11(4):305-309. doi: 10.1016/j.dsx.2016.09.009. Epub 2016 Sep 4. Diabetes Metab Syndr. 2017. PMID: 27612394 Review.
-
Glycation & the RAGE axis: targeting signal transduction through DIAPH1.Expert Rev Proteomics. 2017 Feb;14(2):147-156. doi: 10.1080/14789450.2017.1271719. Epub 2016 Dec 22. Expert Rev Proteomics. 2017. PMID: 27967251 Free PMC article. Review.
Cited by
-
Glyoxalase I disruption and external carbonyl stress impair mitochondrial function in human induced pluripotent stem cells and derived neurons.Transl Psychiatry. 2021 May 8;11(1):275. doi: 10.1038/s41398-021-01392-w. Transl Psychiatry. 2021. PMID: 33966051 Free PMC article.
-
Combined therapeutic strategy based on blocking the deleterious effects of AGEs for accelerating diabetic wound healing.Regen Biomater. 2024 Jun 5;11:rbae062. doi: 10.1093/rb/rbae062. eCollection 2024. Regen Biomater. 2024. PMID: 39323743 Free PMC article.
-
Advanced Glycation End-Products Acting as Immunomodulators for Chronic Inflammation, Inflammaging and Carcinogenesis in Patients with Diabetes and Immune-Related Diseases.Biomedicines. 2024 Jul 31;12(8):1699. doi: 10.3390/biomedicines12081699. Biomedicines. 2024. PMID: 39200164 Free PMC article. Review.
-
Composite dietary antioxidant index and sleep health: a new insight from cross-sectional study.BMC Public Health. 2024 Feb 26;24(1):609. doi: 10.1186/s12889-024-18047-2. BMC Public Health. 2024. PMID: 38408934 Free PMC article.
-
A Study on the Protective Effect of sRAGE-MSCs in a Rodent Reperfusion Model of Myocardial Infarction.Int J Mol Sci. 2022 Dec 9;23(24):15630. doi: 10.3390/ijms232415630. Int J Mol Sci. 2022. PMID: 36555270 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources